Gene · 9118
Papers2,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| One-Pot Isothermal Nucleic Acid Amplification Assisted CRISPR/Cas Detection Technology: Challenges, Strategies, and Perspectives. | Adv Sci (Weinh) | 2025 | 40884263 | PubTator, text mining | PubMed |
| The Yin and Yang of Heartbeats: Magnesium-Calcium Antagonism Is Essential for Cardiac Excitation-Contraction Coupling. | Cells | 2025 | 40862759 | PubTator, text mining | PubMed |
| Sevoflurane inhibition of the developmentally expressed neuronal sodium channel Nav1.3. | Sci Rep | 2025 | 40830395 | PubTator, text mining | PubMed |
| Multivariate genome-wide association analysis of dyslexia and quantitative reading skill improves gene discovery. | Transl Psychiatry | 2025 | 40825760 | PubTator, text mining | PubMed |
| The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels. | Am J Physiol Heart Circ Physiol | 2025 | 40796268 | PubTator, text mining | PubMed |
| Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes. | Am J Physiol Heart Circ Physiol | 2025 | 40789177 | PubTator, text mining | PubMed |
| Disparities in health services and outcomes by National Health Insurance membership type for ischemic heart disease and stroke in Indonesia: analysis of claims, 2017-2022. | Glob Health Res Policy | 2025 | 40745615 | PubTator, text mining | PubMed |
| A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. | Nat Commun | 2025 | 40744913 | PubTator, text mining | PubMed |
| Exploring patient's clinical outcomes, hospital costs, and satisfaction after the implementation of integrated clinical pathway-based nursing practice model. | Cost Eff Resour Alloc | 2025 | 40739272 | PubTator, text mining | PubMed |
| Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations. | Genome Res | 2025 | 40675818 | PubTator, text mining | PubMed |
| Mind the midpoints: Rethinking variability in cardiac INa. | J Gen Physiol | 2025 | 40668223 | PubTator, text mining | PubMed |
| Variability in reported midpoints of (in)activation of cardiac INa. | J Gen Physiol | 2025 | 40668222 | PubTator, text mining | PubMed |
| Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools. | PLoS Comput Biol | 2025 | 40608827 | PubTator, text mining | PubMed |
| AI-assisted multi-OMICS analysis reveals new markers for the prediction of AD. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40441366 | PubTator, text mining | PubMed |
| Eslicarbazepine, a third-generation anti-seizure medication, inhibits INa but stimulates IK(M). | Neurochem Int | 2025 | 40345391 | PubTator, text mining | PubMed |
| Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control. | Commun Biol | 2025 | 40155499 | PubTator, text mining | PubMed |
| Cardioprotective effects of semaglutide on isolated human ventricular myocardium. | Eur J Heart Fail | 2025 | 40107718 | PubTator, text mining | PubMed |
| Gene therapy targeting INa to treat life-threatening arrhythmias: beyond proof-of-concept? | Eur Heart J | 2025 | 39981909 | PubTator, text mining | PubMed |
| SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias. | Eur Heart J | 2025 | 39973098 | PubTator, text mining | PubMed |
| SCN5A variant type-dependent risk prediction in Brugada syndrome. | Europace | 2025 | 39931825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9118/papers?page=3